Abilita Therapeutics

Developer of therapeutics to target membrane proteins

placeSan Diego, California, United States calendar_todayFounded 2014 language abilitatx.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace active. Cited 54 times.

YearFilings
20251

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon